Literature DB >> 21165998

Role of FDG-PET staging in selecting the optimum patient for hepatic resection of metastatic colorectal cancer.

Steven M Strasberg1, Farrokh Dehdashti.   

Abstract

Staging by FDG-PET of patients who are candidates for surgical treatment of colorectal metastases is an essential part of management of this problem. FDG-PET is highly sensitive and specific for intrahepatic colorectal tumors and the most sensitive test for extrahepatic tumors. FDG-PET alters management in 25% of patients, reducing futile laparotomies and hepatectomies.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21165998     DOI： 10.1002/jso.21729

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  4 in total

Review 1.  [Rational imaging of metastasized tumor diseases].

Authors:  H J Stemmler; M Schlemmer; S Reilich
Journal:  Internist (Berl)       Date:  2013-07       Impact factor: 0.743

2.  Added value of FDG-PET imaging in the diagnostic workup for yttrium-90 radioembolisation in patients with colorectal cancer liver metastases.

Authors:  Charlotte E N M Rosenbaum; M A A J van den Bosch; W B Veldhuis; J E Huijbregts; M Koopman; M G E H Lam
Journal:  Eur Radiol       Date:  2012-10-31       Impact factor: 5.315

3.  Indeterminate pulmonary nodules represent lung metastases in a significant portion of patients undergoing liver resection for malignancy.

Authors:  Stephanie Downs-Canner; Runalia Bahar; Srinevas K Reddy; Jon S Cardinal; J Wallis Marsh; David A Geller; Allan Tsung
Journal:  J Gastrointest Surg       Date:  2012-10-20       Impact factor: 3.452

4.  Consistent surgeon evaluations of three-dimensional rendering of PET/CT scans of the abdomen of a patient with a ductal pancreatic mass.

Authors:  Matthew E Wampole; John C Kairys; Edith P Mitchell; Martha L Ankeny; Mathew L Thakur; Eric Wickstrom
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.